{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:09:36Z","timestamp":1761059376686},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1756-8722-5-45","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T16:14:51Z","timestamp":1343837691000},"source":"Crossref","is-referenced-by-count":16,"title":["The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells"],"prefix":"10.1186","volume":"5","author":[{"given":"Christina","family":"Halsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Docherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mhairi","family":"McNeill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Le Brocq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,1]]},"reference":[{"key":"256_CR1","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1128\/MCB.25.4.1215-1227.2005","volume":"25","author":"R Ferreira","year":"2005","unstructured":"Ferreira R, Ohneda K, Yamamoto M, Philipsen S: GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol. 2005, 25: 1215-1227. 10.1128\/MCB.25.4.1215-1227.2005.","journal-title":"Mol Cell Biol"},{"key":"256_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.semcdb.2004.11.002","volume":"16","author":"JD Crispino","year":"2005","unstructured":"Crispino JD: GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol. 2005, 16: 137-147. 10.1016\/j.semcdb.2004.11.002.","journal-title":"Semin Cell Dev Biol"},{"key":"256_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bcmd.2003.08.001","volume":"31","author":"ME Greene","year":"2003","unstructured":"Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD: Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down Syndrome. Blood Cells Mol Dis. 2003, 31: 351-356. 10.1016\/j.bcmd.2003.08.001.","journal-title":"Blood Cells Mol Dis"},{"key":"256_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng955","volume":"32","author":"J Wechsler","year":"2002","unstructured":"Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, Crispino JD: Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down Syndrome. Nat Genet. 2002, 32: 148-152. 10.1038\/ng955.","journal-title":"Nat Genet"},{"key":"256_CR5","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1046\/j.1365-2141.2003.04229.x","volume":"120","author":"A Zipursky","year":"2003","unstructured":"Zipursky A: Transient leukaemia\u2013a benign form of leukaemia in newborn infants with trisomy 21. Br J Haematol. 2003, 120: 930-938. 10.1046\/j.1365-2141.2003.04229.x.","journal-title":"Br J Haematol"},{"key":"256_CR6","doi-asserted-by":"publisher","first-page":"8592","DOI":"10.1128\/MCB.25.19.8592-8606.2005","volume":"25","author":"C Kuhl","year":"2005","unstructured":"Kuhl C, Atzberger A, Iborra F, Nieswandt B, Porcher C, Vyas P: GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1. Mol Cell Biol. 2005, 25: 8592-8606. 10.1128\/MCB.25.19.8592-8606.2005.","journal-title":"Mol Cell Biol"},{"key":"256_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng1566","volume":"37","author":"Z Li","year":"2005","unstructured":"Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH: Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat Genet. 2005, 37: 613-619. 10.1038\/ng1566.","journal-title":"Nat Genet"},{"key":"256_CR8","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1182\/blood-2005-02-0551","volume":"106","author":"AG Muntean","year":"2005","unstructured":"Muntean AG, Crispino JD: Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development. Blood. 2005, 106: 1223-1231. 10.1182\/blood-2005-02-0551.","journal-title":"Blood"},{"key":"256_CR9","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/10428190500485810","volume":"47","author":"AG Muntean","year":"2006","unstructured":"Muntean AG, Ge Y, Taub JW, Crispino JD: Transcription factor GATA-1 and Down Syndrome leukemogenesis. Leuk Lymphoma. 2006, 47: 986-997. 10.1080\/10428190500485810.","journal-title":"Leuk Lymphoma"},{"key":"256_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ng1825","volume":"38","author":"LM Hollanda","year":"2006","unstructured":"Hollanda LM, Lima CS, Cunha AF, Albuquerque DM, Vassallo J, Ozelo MC, Joazeiro PP, Saad ST, Costa FF: An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. Nat Genet. 2006, 38: 807-812. 10.1038\/ng1825.","journal-title":"Nat Genet"},{"key":"256_CR11","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1182\/blood-2009-06-227629","volume":"115","author":"KA Alford","year":"2010","unstructured":"Alford KA, Slender A, Vanes L, Li Z, Fisher EM, Nizetic D, Orkin SH, Roberts I, Tybulewicz VL: Perturbed hematopoiesis in the Tc1 mouse model of Down Syndrome. Blood. 2010, 115: 2928-2937. 10.1182\/blood-2009-06-227629.","journal-title":"Blood"},{"key":"256_CR12","doi-asserted-by":"publisher","first-page":"11598","DOI":"10.1073\/pnas.92.25.11598","volume":"92","author":"R Calligaris","year":"1995","unstructured":"Calligaris R, Bottardi S, Cogoi S, Apezteguia I, Santoro C: Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proc Natl Acad Sci U S A. 1995, 92: 11598-11602. 10.1073\/pnas.92.25.11598.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"256_CR13","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1182\/blood-2010-02-267930","volume":"115","author":"C Halsey","year":"2010","unstructured":"Halsey C, Tunstall O, Gibson B, Roberts I, Graham G: Role of GATA-1s in early hematopoiesis and differences between alternative splicing in human and murine GATA-1. Blood. 2010, 115: 3415-3416. 10.1182\/blood-2010-02-267930.","journal-title":"Blood"},{"key":"256_CR14","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1182\/blood-2008-04-152967","volume":"112","author":"O Tunstall-Pedoe","year":"2008","unstructured":"Tunstall-Pedoe O, Roy A, Karadimitris A, de la Fuente J, Fisk NM, Bennett P, Norton A, Vyas P, Roberts I: Abnormalities in the myeloid progenitor compartment in down syndrome fetal liver precede acquisition of GATA1 mutations. Blood. 2008, 112: 4507-4511. 10.1182\/blood-2008-04-152967.","journal-title":"Blood"},{"key":"256_CR15","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1182\/blood-2006-09-048322","volume":"110","author":"L Gutierrez","year":"2007","unstructured":"Gutierrez L, Nikolic T, van Dijk TB, Hammad H, Vos N, Willart M, Grosveld F, Philipsen S, Lambrecht BN: Gata1 regulates dendritic-cell development and survival. Blood. 2007, 110: 1933-1941. 10.1182\/blood-2006-09-048322.","journal-title":"Blood"},{"key":"256_CR16","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.4049\/jimmunol.181.5.3353","volume":"181","author":"CS McKimmie","year":"2008","unstructured":"McKimmie CS, Fraser AR, Hansell C, Gutierrez L, Philipsen S, Connell L, Rot A, Kurowska-Stolarska M, Carreno P, Pruenster M: Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol. 2008, 181: 8171-8181.","journal-title":"J Immunol"},{"key":"256_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00251-010-0444-1","volume":"62","author":"N Shimokawa","year":"2010","unstructured":"Shimokawa N, Nishiyama C, Nakano N, Maeda K, Suzuki R, Hara M, Fukai T, Tokura T, Miyajima H, Nakao A: Suppressive effects of transcription factor GATA-1 on cell type-specific gene expression in dendritic cells. Immunogenetics. 2010, 62: 421-429. 10.1007\/s00251-010-0444-1.","journal-title":"Immunogenetics"},{"key":"256_CR18","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1182\/blood-2003-04-1154","volume":"102","author":"N Suzuki","year":"2003","unstructured":"Suzuki N, Suwabe N, Ohneda O, Obara N, Imagawa S, Pan X, Motohashi H, Yamamoto M: Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels. Blood. 2003, 102: 3575-3583. 10.1182\/blood-2003-04-1154.","journal-title":"Blood"},{"key":"256_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/278364a0","volume":"278","author":"LC Andersson","year":"1979","unstructured":"Andersson LC, Jokinen M, Gahmberg CG: Induction of erythroid differentiation in the human leukaemia cell line K562. Nature. 1979, 278: 364-365. 10.1038\/278364a0.","journal-title":"Nature"},{"key":"256_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0145-2126(84)90143-7","volume":"8","author":"PA Tetteroo","year":"1984","unstructured":"Tetteroo PA, Massaro F, Mulder A, Schreuder-van Gelder R, von dem Borne AE: Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leuk Res. 1984, 8: 197-206. 10.1016\/0145-2126(84)90143-7.","journal-title":"Leuk Res"},{"key":"256_CR21","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1073\/pnas.0511150103","volume":"103","author":"JP Bourquin","year":"2006","unstructured":"Bourquin JP, Subramanian A, Langebrake C, Reinhardt D, Bernard O, Ballerini P, Baruchel A, Cave H, Dastugue N, Hasle H: Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci U S A. 2006, 103: 3339-3344. 10.1073\/pnas.0511150103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"256_CR22","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2005-06-2219","volume":"107","author":"Y Ge","year":"2006","unstructured":"Ge Y, Dombkowski AA, LaFiura KM, Tatman D, Yedidi RS, Stout ML, Buck SA, Massey G, Becton DL, Weinstein HJ: Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down Syndrome megakaryocytic leukemia. Blood. 2006, 107: 1570-1581. 10.1182\/blood-2005-06-2219.","journal-title":"Blood"},{"key":"256_CR23","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1126\/science.1439790","volume":"258","author":"K Georgopoulos","year":"1992","unstructured":"Georgopoulos K, Moore DD, Derfler B: Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science. 1992, 258: 808-812. 10.1126\/science.1439790.","journal-title":"Science"},{"key":"256_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1634\/stemcells.19-5-397","volume":"19","author":"RA Shivdasani","year":"2001","unstructured":"Shivdasani RA: Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells. 2001, 19: 397-407. 10.1634\/stemcells.19-5-397.","journal-title":"Stem Cells"},{"key":"256_CR25","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1182\/blood-2005-09-3846","volume":"108","author":"H Sakamoto","year":"2006","unstructured":"Sakamoto H, Dai G, Tsujino K, Hashimoto K, Huang X, Fujimoto T, Mucenski M, Frampton J, Ogawa M: Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development. Blood. 2006, 108: 896-903. 10.1182\/blood-2005-09-3846.","journal-title":"Blood"},{"key":"256_CR26","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1074\/jbc.275.8.5553","volume":"275","author":"I Matsumura","year":"2000","unstructured":"Matsumura I, Tanaka H, Kawasaki A, Odajima J, Daino H, Hashimoto K, Wakao H, Nakajima K, Kato T, Miyazaki H, Kanakura Y: Increased D-type cyclin expression together with decreased cdc2 activity confers megakaryocytic differentiation of a human thrombopoietin-dependent hematopoietic cell line. J Biol Chem. 2000, 275: 5553-5559. 10.1074\/jbc.275.8.5553.","journal-title":"J Biol Chem"},{"key":"256_CR27","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood.V86.6.2146.bloodjournal8662146","volume":"86","author":"S Pearson-White","year":"1995","unstructured":"Pearson-White S, Deacon D, Crittenden R, Brady G, Iscove N, Quesenberry PJ: The ski\/sno protooncogene family in hematopoietic development. Blood. 1995, 86: 2146-2155.","journal-title":"Blood"},{"key":"256_CR28","doi-asserted-by":"publisher","first-page":"10118","DOI":"10.1128\/MCB.24.23.10118-10125.2004","volume":"24","author":"N Ueki","year":"2004","unstructured":"Ueki N, Zhang L, Hayman MJ: Ski negatively regulates erythroid differentiation through its interaction with GATA1. Mol Cell Biol. 2004, 24: 10118-10125. 10.1128\/MCB.24.23.10118-10125.2004.","journal-title":"Mol Cell Biol"},{"key":"256_CR29","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1182\/blood-2010-09-306258","volume":"118","author":"S Teichler","year":"2011","unstructured":"Teichler S, Illmer T, Roemhild J, Ovcharenko D, Stiewe T, Neubauer A: MicroRNA29a regulates the expression of the nuclear oncogene Ski. Blood. 2011, 118: 1899-1902. 10.1182\/blood-2010-09-306258.","journal-title":"Blood"},{"key":"256_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.leu.2404093","volume":"20","author":"M Ritter","year":"2006","unstructured":"Ritter M, Kattmann D, Teichler S, Hartmann O, Samuelsson MK, Burchert A, Bach JP, Kim TD, Berwanger B, Thiede C: Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia. 2006, 20: 437-443. 10.1038\/sj.leu.2404093.","journal-title":"Leukemia"},{"key":"256_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1101\/gad.13.4.412","volume":"13","author":"T Nomura","year":"1999","unstructured":"Nomura T, Khan MM, Kaul SC, Dong HD, Wadhwa R, Colmenares C, Kohno I, Ishii S: Ski is a component of the histone deacetylase complex required for transcriptional repression by mad and thyroid hormone receptor. Genes Dev. 1999, 13: 412-423. 10.1101\/gad.13.4.412.","journal-title":"Genes Dev"},{"key":"256_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/leu.2010.276","volume":"25","author":"A Quintas-Cardama","year":"2011","unstructured":"Quintas-Cardama A, Santos FP, Garcia-Manero G: Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia. Leukemia. 2011, 25: 226-235. 10.1038\/leu.2010.276.","journal-title":"Leukemia"},{"key":"256_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0145-2126(90)90002-Q","volume":"14","author":"R Alitalo","year":"1990","unstructured":"Alitalo R: Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts. Leuk Res. 1990, 14: 501-514. 10.1016\/0145-2126(90)90002-Q.","journal-title":"Leuk Res"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-5-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-8722-5-45\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-5-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T05:57:49Z","timestamp":1594533469000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/1756-8722-5-45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["256"],"URL":"https:\/\/doi.org\/10.1186\/1756-8722-5-45","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,1]]},"article-number":"45"}}